Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Wulff

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
Mabs|March 2, 2018
A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3Janna Bednenko, Rian Harriman, Lore Mariën, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2005
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brainHorea Rus, Carlos A Pardo, Lina Hu, et al.
Elife|December 28, 2022
Computational design of peptides to target Na<sub>V</sub>1.7 channel with high potency and selectivity for the treatment of painPhuong T Nguyen, Hai M Nguyen, Karen M Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2025
Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel K<sub>Ca</sub>3.1Seow Theng Ong, Young-Woo Nam, Joshua A Nasburg, et al.
Acta Neuropathologica Communications|March 19, 2025
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxicationThomas J Blackmon, Jeremy A MacMahon, Pedro N Bernardino, et al.
RSC Advances|December 5, 2024
The novel quinoline derivative SKA-346 as a K<sub>Ca</sub>3.1 channel selective activatorBrandon Han Siang Wong, Heesung Shim, Stephanie Shee Min Goay, et al.
Journal of Medicinal Chemistry|August 1, 2014
Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacyKin Sing Stephen Lee, Jun-Yan Liu, Karen M Wagner, et al.
Basic & Clinical Pharmacology & Toxicology|January 29, 2016
Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular BedAida Oliván-Viguera, Marta Sofía Valero, Estéfano Pinilla, et al.
Journal of Medicinal Chemistry|April 28, 2018
Correction to Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo EfficacyKin Sing Stephen Lee, Jun-Yan Liu, Karen M Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's diseaseSupriya Ramesha, Sruti Rayaprolu, Christine A Bowen, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Mabs|March 2, 2018
A multiplatform strategy for the discovery of conventional monoclonal antibodies that inhibit the voltage-gated potassium channel Kv1.3Janna Bednenko, Rian Harriman, Lore Mariën, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2005
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brainHorea Rus, Carlos A Pardo, Lina Hu, et al.
Elife|December 28, 2022
Computational design of peptides to target Na<sub>V</sub>1.7 channel with high potency and selectivity for the treatment of painPhuong T Nguyen, Hai M Nguyen, Karen M Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2025
Design and structural basis of selective 1,4-dihydropyridine inhibitors of the calcium-activated potassium channel K<sub>Ca</sub>3.1Seow Theng Ong, Young-Woo Nam, Joshua A Nasburg, et al.
Acta Neuropathologica Communications|March 19, 2025
Spatiotemporal perturbations of the plasminogen activation system in a rat model of acute organophosphate intoxicationThomas J Blackmon, Jeremy A MacMahon, Pedro N Bernardino, et al.
RSC Advances|December 5, 2024
The novel quinoline derivative SKA-346 as a K<sub>Ca</sub>3.1 channel selective activatorBrandon Han Siang Wong, Heesung Shim, Stephanie Shee Min Goay, et al.
Journal of Medicinal Chemistry|August 1, 2014
Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacyKin Sing Stephen Lee, Jun-Yan Liu, Karen M Wagner, et al.
Basic & Clinical Pharmacology & Toxicology|January 29, 2016
Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular BedAida Oliván-Viguera, Marta Sofía Valero, Estéfano Pinilla, et al.
Journal of Medicinal Chemistry|April 28, 2018
Correction to Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro Target Residence Time and in Vivo EfficacyKin Sing Stephen Lee, Jun-Yan Liu, Karen M Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2021
Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's diseaseSupriya Ramesha, Sruti Rayaprolu, Christine A Bowen, et al.
Pageof 23